Moreover, serum TNF‐α (398.15 ng/L vs. 350.65 ng/L, p = .001), FABP4 (1644.00 ng/L vs. 1553.00 ng/L, p = .032), ANGPTL3 (57.60 ng/mL vs. 52.85 ng/mL, p = .003), ANGPTL4 (37.35 ng/mL vs. 35.20 ng/mL, p = .009) levels were significantly higher in the CAD group than in the non‐CAD group (Table 1). This evidence concerns the gene TNF and coronary artery disorder.